Journal of Oleo Science · 2002 · 13 citations · 8 references
MedicineNutritional SciencesPharmacologyClinical PharmacologyHuman NutritionPharmacovigilanceDietary Supplement ToxicityRegulatory PharmacologyWeight ManagementAdverse Effect CharacterizationDietary Supplement PharmacovigilanceEvidence-based Herbal SafetyHerbal SupplementsLowest-observed-adverse-effect LevelNo-observed-adverse-effect LevelPharmacovigilance Of Herbal ProductsSingle-dose Administration
(−)-Hydroxycitric acid (HCA), a competitive inhibitor of ATP-citrate lyase, is frequently used in dietary supplements for weight loss in humans, and is the principal acid in the rinds of Garcinia cambogia, a fruit native to Asia. NOAEL (no-observed-adverse-effect level) of G. cambogia extract was determined in the present study and examination was made of adverse effects of high-dose administration to 44 healthy volunteers who had received 4000 mg HCA. No adverse effect was noted in any subjects. NOAEL of G. cambogia extract was estimated as more than 4000 mg HCA. Sequential-high-doses administration study was condusted in subjects who had been given 3000 mg HCA daily for 10 days. Blood samples were used to obtain clinical data before and after treatment. The clinical data were essentially the same for either time. G. cambogia extract at more than 3000 mg HCA may be considered safe for healthy persons.
8
Garcinia cambogia (Hydroxycitric Acid) as a Potential Antiobesity Agent
S. B. Heymsfield, David B. Allison, Joseph R. Vasselli et al. · JAMA · 1998 · 345 citations
Agriculture, Nutrition, Pharmacology +17
Citrate and the Conversion of Carbohydrate into Fat
John Watson, John M. Lowenstein · Journal of Biological Chemistry · 1970 · 257 citations · Full text
Effect of (−)‐hydroxycitrate upon the accumulation of lipid in the rat: II. Appetite
Ann C. Sullivan, Joseph Triscari, James G. Hamilton et al. · Lipids · 1974 · 122 citations